Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives - Annals of Oncology
Clinical management of metastatic colorectal cancer in the era of precision medicine - Ciardiello - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Les biomarqueurs prédictifs dans le cancer colorectal
Precision medicine for metastatic colorectal cancer in clinical practice - Julian E. Riedesser, Matthias P. Ebert, Johannes Betge, 2022
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. - Abstract - Europe PMC
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer | Pharmacogenomics
Biomarqueurs des cancers colorectaux utiles en pratique clinique – FMC-HGE
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
Biomarkers in Targeted Therapy for Colorectal Cancer
New combination therapy offers bowel cancer patients extra treatment option
Cancers | Free Full-Text | Immune Resistance and EGFR Antagonists in Colorectal Cancer
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer | Aging
Frontiers | The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
Frontiers | Targeting EGFR in Esophagogastric Cancer
Different EGFR signalling pathways induced by the interaction between... | Download Scientific Diagram
Epidermal growth factor receptor (EGFR)-related signaling pathway in... | Download Scientific Diagram
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution - ScienceDirect
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
IJMS | Free Full-Text | Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
RESISTANCE TO ANTI-EGFR THERAPIES IN COLORECTAL CANCER – Sanguine Bio Researcher Blog
